|

SwissTAVI Registry

RECRUITINGSponsored by Insel Gruppe AG, University Hospital Bern
Actively Recruiting
SponsorInsel Gruppe AG, University Hospital Bern
Started2011-02
Est. completion2025-05
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT01368250

Summary

The purpose of this prospective multi-center, observational national registry in Switzerland is to obtain clinical baseline, procedural and follow-up data of all patients treated with TAVI in Switzerland and to assess short, mid- and long-term clinical outcome data of the CE approved devices. All centers in Switzerland implanting the CE approved devices for TAVI will be invited to include patients in the registry. Each site will collect baseline and procedural data as well as clinical outcome data up to five years.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Native aortic valve stenosis
* Native aortic valve regurgitation
* Degenerated aortic bioprosthesis requiring treatment

Exclusion Criteria

* Patients refuses informed consent to participate in the registry
* Contraindication for TAVI
* High probability of non-adherence to the follow up - requirements

Conditions2

Aortic Valve Disease MixedHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.